P40337 (VHL_HUMAN) Homo sapiens (Human)

von Hippel-Lindau disease tumor suppressor UniProtKBInterProSTRINGInteractive Modelling

213 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3); 4 identical sequences: Homo sapiens: A0A024R2F2; Pan troglodytes: K7BID8, A0A6D2WU70; Pan paniscus: A0A2R9B5S8

Available Structures

104 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q13098; Q13617; Q15369; Q15370; Q15843; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
54-213
Assess
Open non-crosslinked structure Brd4BD2-MZ1-(NEDD8)-CRL2VHL Heteromer
L7N190; O60885; Q13617; Q15370;
54-213
759;ZN;
Assess
(NEDD8)-CRL2VHL-MZ1-Brd4BD2-Ub(G76S, K48C)-UBE2R1(C93K, S138C, C191S, C223S)-Ub Heteromer
L7N190; O60885; P0CG48; P49427; Q13617; Q15370; Q15843;
54-213
759;ZN;
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with Aryl linker Heteromer
P61964; Q15369; Q15370;
57-210
10×SCN;Q43;EDO;K;
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #1) Heteromer
P61964; Q15369; Q15370;
57-209
15×SCN; 13×EDO;P6G;Q3X;
Assess
BRG1 bromodomain in complex with VBC via compound 17 Heteromer
P51532; Q15369; Q15370;
61-213
PO4;GOL;VLH;
Assess
Crystal structure of PROTAC 1 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P51531; Q15369; Q15370;
59-210
FX8; 11×EDO;FMT;
Assess
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
Q15370; Q2KII4; Q99814;
60-210
GOL;
Assess
PROTAC6 mediated complex of VHL:EloB:EloC and Bcl-xL Heteromer
Q07817; Q15369; Q15370;
59-209
QL8; 17×EDO;GOL; 12×IOD;
Assess
Crystal structure of compound 6 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:… Heteromer
P51531; Q15369; Q15370;
60-210
IFF;
Assess
Crystal structure of HIF-2alpha-pVHL-elongin B-elongin C Heteromer
Q15369; Q15370; Q99814;
59-209
Assess
Crystal structure of VHL in complex with H313, a Helicon Polypeptide Heteromer
Q15369; Q15370;
58-208
WHL;
Assess
Structure of a HIF-1a-pVHL-ElonginB-ElonginC Complex Heteromer
Q15369; Q15370; Q16665;
60-209
Assess
Crystal structure of a hydroxylated HIF-1 alpha peptide bound to the pVHL/elongin-C/elongin-B compl… Heteromer
Q15369; Q15370; Q16665;
61-210
SO4;
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with PEG linker (conformation #2) Heteromer
P61964; Q15369; Q15370;
58-207
SCN;Q3X;EDO;
Assess
CRYSTAL STRUCTURE OF AT7 IN COMPLEX WITH THE SECOND BROMODOMAIN OF HUMAN BRD4 AND PVHL:ELONGINC:ELO… Heteromer
O60885; Q15369; Q15370;
61-210
IZR;
Assess
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
Q15369; Q15370; Q16665;
60-208
SO4;F4K;GOL;
Assess
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA4 and pVHL:ElonginC:El… Heteromer
P51532; Q15369; Q15370;
61-209
FWZ;DMS;
Assess
Structure of pVHL-elongin B-elongin C (VCB) in complex with hydroxylated-HIF-2alpha (523-542) in th… Heteromer
Q15369; Q15370; Q99814;
60-208
FMT;
Assess
Crystal structure of PROTAC 5 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P51531; Q15369; Q15370;
61-209
IEI;
Assess
Crystal Structure of ligand ACBi1 in complex with bromodomain of human Smarca2 and pVHL:ElonginC:El… Heteromer
P51531; Q15369; Q15370;
60-208
EDO;NA;PEG;87A;
Assess
Crystal structure of pVHL:ElonginC:ElonginB complex bound to PROTAC JW48 Heteromer
Q15369; Q15370;
59-207
SYF;
Assess
Crystal structure of PROTAC 2 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC:El… Heteromer
P51531; Q15369; Q15370;
60-208
EDO;FWZ;EPE;
Assess
The PROTAC MZ1 in complex with the second bromodomain of Brd4 and pVHL:ElonginC:ElonginB Heteromer
O60885; Q15369; Q15370;
61-209
759;
Assess
Ternary complex between VCB, BRD4-BD2 and PROTAC 51 Heteromer
O60885; Q15369; Q15370;
61-209
QLX;
Assess
SelDeg51 in complex with FKBP51FK1 domain and pVHL:EloB:EloC Heteromer
Q13451; Q15369; Q15370;
61-209
XZW;
Assess
Ternary complex between VCB, BRD4-BD2 and PROTAC 48 Heteromer
O60885; Q15369; Q15370;
61-209
QIY;
Assess
E3:PROTAC:target ternary complex structure (VCB/WH244/BCL-2) Heteromer
P10415; Q15369; Q15370;
60-208
YFH;
Assess
Crystal structure of macrocyclic PROTAC 1 in complex with the second bromodomain of human Brd4 and … Heteromer
O60885; Q15369; Q15370;
61-209
LFE;
Assess
Ubiquitin ligation to neosubstrate by a cullin-RING E3 ligase & Cdc34: NEDD8-CUL2-RBX1-ELOB/C-VHL-M… Heteromer
O60885; P0CG48; P62877; Q13617; Q15369; Q15370; Q712K3;
61-209
ZN;SY8;759;
Assess
Crystal structure of Protac MS33 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P61964; Q15369; Q15370;
58-205
SCN;EDO;VKA;GOL;NA;
Assess
von Hippel-Lindau protein-ElonginB-ElonginC complex, bound to Hif1- alpha peptide Heteromer
Q15369; Q15370; Q16665;
60-207
GOL;
Assess
Ternary complex of VHL/BRD4-BD1/Compound9 (4-(3,5-difluoropyridin-2-yl)-N-(11-(((S)-1-((2S,4R)-4-hy… Heteromer
O60885; Q15369; Q15370;
61-208
WEP;
Assess
VCB in complex with compound 27 Heteromer
Q15369; Q15370;
62-209
QF3;
Assess
Crystal Structure of compound 4 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; Q15369; Q15370;
60-207
X53;GDP;MG;
Assess
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 8 molecular glue Heteromer
Q15369; Q15370; Q16878;
61-208
A1ACI;CIT;FE2;
Assess
Crystal structure of EloBC-VHL-CDO1 complex bound to compound 4 molecular glue Heteromer
Q15369; Q15370; Q16878;
61-208
3JF;CIT;FE2;
Assess
VHL/Elongin B/Elongin C complex with compound 155 Heteromer
Q15369; Q15370;
61-208
VL6;
Assess
Structure of VHL-EloB-EloC-Cul2 Heteromer
Q13617; Q15369; Q15370;
60-207
Assess
Structural basis of Cullin-2 RING E3 ligase regulation by the COP9 signalosome Heteromer
P61201; P62877; Q03071; Q13098; Q13617; Q15370; Q7L5N1; Q92905; Q99627; Q9BT78; Q9H9Q2; Q9UNS2;
60-207
ZN;
Assess
Ternary complex between VCB, BRD4-BD1 and PROTAC 48 Heteromer
O60885; Q15369; Q15370;
61-207
SO4;EDO;QIY;
Assess
pVHL:EloB:EloC in complex with modified HIF-1a CODD peptide containing (3R,4S)-3-fluoro-4-hydroxypr… Heteromer
Q15369; Q15370; Q16665;
61-207
Assess
Quaternary Complex of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC Homer Heteromer
P61964; Q15369; Q15370;
59-205
8KH;
Assess
VHL recognizes hydroxyproline in RIPK1 Heteromer
Q13546; Q15369; Q15370;
60-206
Assess
Structure of human WDR5 and pVHL:ElonginC:ElonginB bound to PROTAC with C3 linker Heteromer
P61964; Q15369; Q15370;
62-208
Q3R;
Assess
E3:PROTAC:target ternary complex structure (VCB/753b/BCL-xL) Heteromer
Q07817; Q15369; Q15370;
61-207
CAD;GOL;YF8;
Assess
Crystal structure of the VCB complex with compound 1. Heteromer
Q15369; Q15370;
62-207
WBN;CL;
Assess
VCB in complex with compound 32 Heteromer
Q15369; Q15370;
62-207
QF7;
Assess
Co-crystal structure of Compound 11 in complex with the bromodomain of human SMARCA2 and pVHL:Elong… Heteromer
P51531; Q15369; Q15370;
60-205
GOL;FWZ;
Assess
DNA-encoded library (DEL)-enabled discovery of proximity inducing small molecules Heteromer
O60885; Q15369; Q15370;
61-206
X5K;
Assess
VCB in complex with compound 30 Heteromer
Q15369; Q15370;
62-206
QE0;
Assess
VCB in complex with compound 23 Heteromer
Q15369; Q15370;
62-206
QFR;
Assess
Crystal Structure of compound 3 in complex with KRAS G12V C118S GDP and pVHL:ElonginC:ElonginB Heteromer
P01116; Q15369; Q15370;
61-204
GDP;X4R;MG;
Assess
Crystal Structure of ligand ACBI3 in complex with KRAS G12D C118S GDP and pVHL:ElonginC:ElonginB co… Heteromer
P01116; Q15369; Q15370;
61-204
WYL;GDP;MG;
Assess
E3:PROTAC:target ternary complex structure (VCB/753b/BCL-2) Heteromer
P10415; Q15369; Q15370;
61-204
YF8;
Assess
Crystal structure of compound 10 in complex with the bromodomain of human SMARCA2 and pVHL:ElonginC… Heteromer
P51531; Q15369; Q15370;
60-202
IOD;IFJ;
Assess
VCB in complex with compound 26 Heteromer
Q15369; Q15370;
62-204
QE9;
Assess
Crystal structure of Protac MS67 in complex with the WD repeat-containing protein 5 and pVHL:Elongi… Heteromer
P61964; Q15369; Q15370;
62-204
GOL;X6M;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-N-((S)-1-(5-Fluoro-2-methoxy-4-(4-methylthiazol-5-yl)phenyl)… Heteromer
Q15369; Q15370;
62-204
VH3;
Assess
pVHL54-213-EloB-EloC complex_(2S,4R)-4-hydroxy-1-(2-(3-methylisoxazol- 5-yl)acetyl)-N-(4-nitrobenzy… Heteromer
Q15369; Q15370;
62-204
GOL;ZUN;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
Q15369; Q15370;
62-204
VYQ;
Assess
VCB in complex with compound 21 Heteromer
Q15369; Q15370;
62-204
QFF;
Assess
Co-crystal structure of Compound 1 in complex with the bromodomain of human SMARCA4 and pVHL:Elongi… Heteromer
P51532; Q15369; Q15370;
62-204
NA;YHB;PEG;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-y… Heteromer
Q15369; Q15370;
62-203
3JU;
Assess
pVHL:EloB:EloC in complex with VH298 Heteromer
Q15369; Q15370;
62-203
6Z3;
Assess
pVHL54-213-EloB-EloC complex _ (2S,4R)-N-((1,1'-biphenyl)-4-ylmethyl)- 4-hydroxy-1-(2-(3-methylisox… Heteromer
Q15369; Q15370;
63-204
TR0;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetylcyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
Q15369; Q15370;
62-203
9BN;
Assess
THE VHL-ELONGINC-ELONGINB STRUCTURE Heteromer
Q15369; Q15370;
63-204
Assess
pVHL54-213-EloB-EloC complex _ methyl 4-(((2S,4R)-4-hydroxy-1-(2-(3- methylisoxazol-5-yl)acetyl)pyr… Heteromer
Q15369; Q15370;
63-204
ZTD;
Assess
pVHL-EloB-EloB-EloC complex_(2S,4R)-1-(2-chlorophenyl)carbonyl-N-[(4-chlorophenyl)methyl]-4-oxidany… Heteromer
Q15369; Q15370;
62-203
ACT;UCK;
Assess
pVHL54-213-EloB-EloC complex_apo Heteromer
Q15369; Q15370;
63-204
Assess
pVHL54-213-EloB-EloC complex (4R)-4-HYDROXY-1-[(3-METHYLISOXAZOL-5-YL)ACETYL]-N-[4-(1,3-OXAZOL-5-YL… Heteromer
Q15369; Q15370;
63-204
L8B;
Assess
pVHL-ELOB-ELOC complex_(2S,4R)-1-(3-amino-2-methylbenzoyl)-4-hydroxy-N-(4-(4-methylthiazol-5-yl)ben… Heteromer
Q15369; Q15370;
62-202
TG0;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-4-hydroxy-1-((S)-2-(2-hydroxyacetamido)-3,3-dimethylbutanoyl… Heteromer
Q15369; Q15370;
62-202
9BT;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamido-3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-m… Heteromer
Q15369; Q15370;
62-202
3JF;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3-phenylpropanamido)-3,3-dimethylb… Heteromer
Q15369; Q15370;
62-202
3JO;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclobutanecarboxamido)-3,3-dimethylbutanoyl)-4-hy… Heteromer
Q15369; Q15370;
62-202
9BH;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(cyclopropanecarboxamido)-3,3-dimethylbutanoyl)-4-h… Heteromer
Q15369; Q15370;
62-202
9BW;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-3,3-dimethyl-2-(oxetane-3-carboxamido)butanoyl)-4-hyd… Heteromer
Q15369; Q15370;
62-202
9B8;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-3,3-dimethylbutanamido)-3,3-dimeth… Heteromer
Q15369; Q15370;
62-202
3JJ;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(4-methyloxazol-5-yl… Heteromer
Q15369; Q15370;
62-202
3JK;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-((S)-2-acetamido-4-methylpentanamido)-3,3-dimethylb… Heteromer
Q15369; Q15370;
62-202
3JH;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-fluorocyclopropanecarboxamido)-3,3-dimethylbutan… Heteromer
Q15369; Q15370;
62-202
4YY;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(oxazol-5-yl)benzyl)… Heteromer
Q15369; Q15370;
62-202
3JG;
Assess
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-1-ethanoyl-N-[[4-(1,3-… Heteromer
Q15369; Q15370;
62-202
X6C;ACT;
Assess
pVHL:EloB:EloC in complex with modified VH032 containing (3S,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
Q15369; Q15370;
62-202
EXE;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-acetamidocyclopropanecarboxamido)-3,3-dimethylbu… Heteromer
Q15369; Q15370;
62-202
9BK;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carbonyl)-4-hydro… Heteromer
Q15369; Q15370;
62-202
3JS;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-Acetamidopropanethioyl)-4-hydroxy-N-(4-(4-methylthi… Heteromer
Q15369; Q15370;
62-202
DV5;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(4-(thiazol-5-yl)benzyl… Heteromer
Q15369; Q15370;
62-202
3JT;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-(3,3-dimethylbutanoyl)-4-hydroxy-N-(3-methyl-4-(thiazol-5-… Heteromer
Q15369; Q15370;
62-202
3JV;
Assess
pVHL:EloB:EloC in complex with modified VH032 containing (3R,4S)-3-fluoro-4-hydroxyproline (ligand … Heteromer
Q15369; Q15370;
62-202
EXH;
Assess
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
Q15369; Q15370;
62-202
DV8;
Assess
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-Hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carba… Heteromer
Q15369; Q15370;
62-202
DV2;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-(1-Fluorocyclopropane-1-carboxamido)-3,3-dimethylbu… Heteromer
Q15369; Q15370;
62-202
VFO;
Assess
pVHL:EloB:EloC in complex with (2S,4R)-1-((S)-2-acetamidopropanoyl)-4-hydroxy-N-(4-(4-methylthiazol… Heteromer
Q15369; Q15370;
62-202
9B5;
Assess
Ternary complex between VCB, BRD4-BD1 and PROTAC 49 Heteromer
O60885; Q15369; Q15370;
62-202
SO4;QIK;
Assess
pVHL:EloB:EloC in complex with methyl 4H-furo[3,2-b]pyrrole-5-carboxylate Heteromer
Q15369; Q15370;
62-201
ACT;F4E;
Assess
von Hippel Lindau protein:ElonginB:ElonginC complex, in complex with (2S,4R)-N-methyl-1-[2-(3-methy… Heteromer
Q15369; Q15370;
62-201
QD0;
Assess
pVHL:EloB:EloC in complex with 6-chlorothiochroman-4-one Heteromer
Q15369; Q15370;
62-201
F7B;IPA;
Assess
pVHL:EloB:EloC complex, in complex with capped Hydroxyproline Heteromer
Q15369; Q15370;
62-200
ACT;V6F;
Assess
pVHL:EloB:EloC in complex with (4-(1H-pyrrol-1-yl)phenyl)methanol Heteromer
Q15369; Q15370;
63-201
Assess
PROTAC-mediated complex of KRAS with VHL/Elongin-B/Elongin-C/Cullin-2/Rbx1 Heteromer
P01116; P62877; Q13617; Q15369; Q15370;
66-204
ZN;GDP;WYL;
Assess
Crystal structure of the Cul2-Rbx1-EloBC-VHL ubiquitin ligase complex Heteromer
P62877; Q13617; Q15369; Q15370;
157-193
ZN;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
4wqo.1.Amonomer0.8460-207
100.00
Assess

2 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 24wqo.1.Amonomer0.6260-166
100.00
Assess
Isoform 36r7f.1.Imonomer0.861-160
100.00
Assess